Resources Contact Us Home
Modified leukotoxin protein

Image Number 10 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Methods and apparatus for imaging in conjunction with radiotherapy
LED-array package
Portable electric circular saw
2,4-disubstituted pyrimidines useful as kinase inhibitors
Washing machine
Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8
Multicolored light converting LED with minimal absorption
  Randomly Featured Patents
Multiple electrode lead and a system for deep electrical neurostimulation including such a lead
Copper-iron-cobalt-titanium alloy with high mechanical and electrical characteristics and its production process
Liquid silicone rubber coating composition
Educational number game
Terrain avoidance system for transport aircraft
Monolithic fan controller
Cushion system for multi-use child safety seat
Left-handed nonlinear transmission line media
System for mounting elongate structures and wiring
Electrostatic copying process and apparatus